Twist Bioscience launches Twist MRD Express, offering custom molecular residual disease panels with turnaround times starting ...

Curiox Biosystems expands its leadership team and forms a Strategic Advisory Board to support growth of its centrifuge-free ...

Malignant mesothelioma is a rare, life-threatening cancer that develops in the thin tissue lining internal organs, with more ...

The enterprise digital pathology platform, powered by Tribun Health, integrates pathology, radiology, and cardiology imaging ...

Watchmaker Genomics launched a PCR-free whole genome sequencing workflow integrating library prep and normalization.

Genefluence’s rapid PCR test for UTIs is now in clinical use, enabling one-hour detection of pathogens and resistance genes.

Ozelle will present its AI-assisted hematology analyzer at MEDICA 2026, offering CBC, 7-part WBC differentials, and digital ...

FDA clears Sekisui Diagnostics’ rapid combo test for COVID-19 and flu A&B, offering CLIA-waived, 510(k)-cleared pathogen ...

Path Fertility secures $2 million NIH grant to develop and validate a semen-based epigenetic assay for NOA and cancer risk.

Agendia presented data on an AI pathology model that predicts breast cancer recurrence risk from routine biopsy slides.

Abbott launches its Oncodetect MRD test, using WGS to track up to 5,000 variants and improve cancer recurrence detection sensitivity.